Ono Pharmaceutical Co., Ltd. (OPHLY)
USD 3.5
(0.0%)
USD 3.5
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 110.66 Billion | 159.61 Billion | 61.82 Billion | 73.97 Billion | 74.15 Billion | 66.77 Billion |
| Net Income | 127.97 Billion | 143.53 Billion | 105.02 Billion | 100.89 Billion | 79.69 Billion | 65.14 Billion |
| Depreciation & Amortization | 18.14 Billion | 17.45 Billion | 17.72 Billion | 15.82 Billion | 14.21 Billion | 10.62 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -28.76 Billion | 1.43 Billion | -30.1 Billion | -6.51 Billion | 4.92 Billion | 7.39 Billion |
| Other non-cash items | 54.62 Billion | -2.81 Billion | -30.81 Billion | -36.21 Billion | -24.67 Billion | -16.38 Billion |
| Investing Cash Flow | 48.07 Billion | -100.25 Billion | 6.03 Billion | -57.58 Billion | -10.23 Billion | -49.76 Billion |
| Investments in PPE | -20.82 Billion | -14.49 Billion | -12.27 Billion | -20.29 Billion | -22.44 Billion | -29.6 Billion |
| Acquisitions | 903 Million | -9.15 Billion | -6.76 Billion | -13.27 Billion | -14.54 Billion | -7.28 Billion |
| Investment purchases | -36.73 Billion | -140.59 Billion | -58.61 Billion | -81.69 Billion | -45.8 Billion | -56.67 Billion |
| Sales/Maturities of investments | 106.02 Billion | 55.86 Billion | 78.58 Billion | 44.83 Billion | 57.23 Billion | 37.92 Billion |
| Other Investing Activities | -1.28 Billion | 8.12 Billion | 5.11 Billion | 12.84 Billion | 15.31 Billion | 5.87 Billion |
| Financing Cash Flow | -89.84 Billion | -32.48 Billion | -60.23 Billion | -24.75 Billion | -54.72 Billion | -22.27 Billion |
| Debt repayment | - | - | - | - | - | -361 Million |
| Dividends payments | -37.18 Billion | -29.74 Billion | -27.66 Billion | -22.44 Billion | -22.77 Billion | -21.82 Billion |
| Common Stock Repurchased | -50.01 Billion | -1 Million | -30 Billion | -3 Million | -29.58 Billion | -1 Million |
| Common Stock Issuance | - | - | - | - | - | 362 Million |
| Other Financing Activities | -9 Million | -2.74 Billion | -2.56 Billion | -2.3 Billion | -2.36 Billion | -451 Million |
| Accounts receivables | -19.78 Billion | -14.51 Billion | -15.28 Billion | -7.17 Billion | -793 Million | 1.25 Billion |
| Accounts payables | -1.83 Billion | 13.09 Billion | 8.17 Billion | 6.36 Billion | 1.99 Billion | 998 Million |
| Inventory | -3.42 Billion | -2.94 Billion | -2.46 Billion | -6.1 Billion | -173 Million | -1.56 Billion |
| Other working capital | -3.72 Billion | 5.8 Billion | -20.53 Billion | 410 Million | 3.89 Billion | 6.71 Billion |
| Cash at beginning of period | 96.13 Billion | 69.11 Billion | 61.04 Billion | 69 Billion | 59.98 Billion | 65.27 Billion |
| Cash at end of period | 166.14 Billion | 96.13 Billion | 69.11 Billion | 61.04 Billion | 69 Billion | 59.98 Billion |
| Capital Expenditure | -20.82 Billion | -14.49 Billion | -12.27 Billion | -20.29 Billion | -22.44 Billion | -29.6 Billion |
| Effect of forex changes on cash | 1.11 Billion | 155 Million | 436 Million | 403 Million | -179 Million | -24 Million |
| Net cash flow / Change in cash | 70 Billion | 27.02 Billion | 8.06 Billion | -7.96 Billion | 9.02 Billion | -5.29 Billion |
| Free Cash Flow | 89.83 Billion | 145.11 Billion | 49.55 Billion | 53.68 Billion | 51.71 Billion | 37.17 Billion |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 127.97 Billion | 17.43 Billion | 47.99 Billion | 56.91 Billion | 42.37 Billion | 143.53 Billion |
| Depreciation & Amortization | 18.14 Billion | 4.71 Billion | 4.34 Billion | 4.55 Billion | 4.53 Billion | 17.45 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -28.76 Billion | 19.16 Billion | -5.89 Billion | -16.7 Billion | -24.75 Billion | 1.43 Billion |
| Other non-cash items | 54.62 Billion | -1.43 Billion | -21.66 Billion | 1.58 Billion | -31.78 Billion | -2.81 Billion |
| Investing Cash Flow | 48.07 Billion | 28.7 Billion | -1.34 Billion | 29.9 Billion | -9.19 Billion | -100.25 Billion |
| Investments in PPE | -20.82 Billion | -10.53 Billion | -1.4 Billion | -1.14 Billion | -7.74 Billion | -14.49 Billion |
| Acquisitions | 903 Million | 34 Million | -615 Million | -311 Million | -5.22 Billion | -9.15 Billion |
| Investment purchases | -36.73 Billion | -790 Million | -3.56 Billion | -31.18 Billion | -1.18 Billion | -140.59 Billion |
| Sales/Maturities of investments | 106.02 Billion | 40.19 Billion | 2.55 Billion | 62.96 Billion | 315 Million | 55.86 Billion |
| Other Investing Activities | -1.28 Billion | -195 Million | 1.69 Billion | -411 Million | 4.65 Billion | 8.12 Billion |
| Financing Cash Flow | -89.84 Billion | -14.49 Billion | -28.71 Billion | -29.11 Billion | -17.53 Billion | -32.48 Billion |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -37.18 Billion | -1.03 Billion | -18.1 Billion | -1.22 Billion | -16.82 Billion | -29.74 Billion |
| Common Stock Repurchased | -50.01 Billion | -12.75 Billion | -10.06 Billion | -27.18 Billion | - | -1 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -9 Million | -700 Million | -544 Million | -702 Million | -709 Million | -2.74 Billion |
| Accounts receivables | -19.78 Billion | 14.91 Billion | -8.7 Billion | -17.88 Billion | -8.11 Billion | -14.51 Billion |
| Accounts payables | -1.83 Billion | 5.88 Billion | -180 Million | 1.03 Billion | -8.56 Billion | 13.09 Billion |
| Inventory | -3.42 Billion | -2.09 Billion | 2.14 Billion | 1.84 Billion | -5.31 Billion | -2.94 Billion |
| Other working capital | -3.72 Billion | 459 Million | 841 Million | -1.69 Billion | -2.76 Billion | 5.8 Billion |
| Cash at beginning of period | 96.13 Billion | 102.24 Billion | 107.7 Billion | 60.43 Billion | 96.13 Billion | 69.11 Billion |
| Cash at end of period | 166.14 Billion | 166.14 Billion | 102.24 Billion | 107.7 Billion | 60.43 Billion | 96.13 Billion |
| Capital Expenditure | -20.82 Billion | -10.53 Billion | -1.4 Billion | -1.14 Billion | -7.74 Billion | -14.49 Billion |
| Effect of forex changes on cash | 1.11 Billion | 517 Million | -183 Million | 121 Million | 661 Million | 155 Million |
| Net cash flow / Change in cash | 70 Billion | 63.89 Billion | -5.45 Billion | 47.27 Billion | -35.7 Billion | 27.02 Billion |
| Free Cash Flow | 89.83 Billion | 38.62 Billion | 23.37 Billion | 45.21 Billion | -17.38 Billion | 145.11 Billion |
9567
4170
ROHCY
TOMZ
PURA
RUSHIL